Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Coursera

Molecular Tumor Board 2021-22

University of Barcelona via Coursera

Overview

Se trata de un curso que nace a raíz de una de las sesiones formativas que realiza cada 15 días el Servicio de Oncología Médica del Hospital Clínic de Barcelona (HCB). En este curso se presentan casos clínicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento específico del impacto clínico del perfil molecular en tumores sólidos. Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncología médica. Cada seminario que conforma el curso lo presenta un profesional de una patología diferente del Servicio de Oncología Médica del HCB. El curso está ACREDITADO por el "Consell Català de la Formació Continuada de les Professions Sanitàries (CCFCPS)" con 4,2 créditos.

Syllabus

  • Thoracic Tumor - Somatic and germinal, both are deletions by Dr. Lucio Ghiglione
    • Cáncer de torax
  • Learning from failures by Dr. Helena Oliveres
  • Selecting patients for PARPis in Ovarian Cancer: ¿How can we best indentify them? by Dr. Lydia Gaba
    • Cáncer de ovario
  • Intrinsic Subtypes and Therapeutic Decision-Making in HR+HER2-negative Metastatic Breast Cancer by Dr. Francesco Schettini
  • DNA repair and clinical evolutiol of metastatic prostate cancer by Dr. Caterina Aversa
    • Cáncer de mama
  • Change in phenotype and somatic BRCA1 mutation in a patient with advanced breast cancer by Dr. Barbara Adamo
    • Cáncer de mama
  • Done right, went wrong by Dr. Victor Albarran
  • Can be guided treatment strategy without somatic molecular profile? by Dr. Juan Carlos Laguna
  • Precision medicine in non-melanoma skin cancer by Dr. Elia Segui
    • Cáncer de piel
  • Unexpected response in a rare tumor by Dr. David Pesantez
    • Cáncer raro
  • Mejorando la supervivencia en cáncer de mama mestatásico by Dr. Maria Vidal
    • Cáncer de mama metastásico
  • Beyond BRCA1 and 2 in ovarian cancer by Dr. Adela Rodríguez
    • Cáncer de Ovario
  • "Not everything is what it seems to be”... The correct interpretation of tumor molecular studies and the importance of a multidisciplinar approach Dr. Belen Pastor
    • Cáncer hereditario
  • Never too late to think twice by Dr. Marta García de Herreros
    • Diagnóstico y abordaje de una neoplasia
  • Do we have predictive biomarkers in urothelial carcinoma (UC) beyond FGFR alterations? by Dr. Oscar Reig
  • Agnostic Biomarker in solid tumors by Dr. Laura Angelats
    • Cáncer genitourinario
  • What acral melanoma hides by Dr. Roberto Martín
    • Cáncer de piel
  • Molecular Family by Dr. Roxana Reyes
    • Biología molecular
  • Is there any rol for precision medicine in rare pacreatic cancer? by Dr. Francis Espósito
    • Cáncer Gástrico
  • Beyond the classical EGFR resistance mechanisms by Teresa Gorria
    • The protein EGFR
  • Breast cancer: Beyond intrinsic subtypes by Raquel Gómez
    • Cáncer de mama
  • Intrahepatic cholangiocarcinoma: beyond chemotherapy by Dr. Iván Victoria
  • Exploiting genomics in serous endometrial cancer by Lydia Gaba
    • Cáncer ginecológico
  • Beyond classical BRAF mutations in melanoma by Dr. Marta García de Herreros
    • Cáncer de piel
  • Can we talk about Precision Immuno-Oncology in HR+ HER2- Breast Cancer? by Elia Seguí
    • Cáncer de mama y inmunoterapia
  • Brain tumor by Estela Pineda
    • Cáncer del SNC

Taught by

Dra. Laura Mezquita Perez, Dr. Aleix Prat Aparicio and Eva Paradell Salinas

Tags

Reviews

Start your review of Molecular Tumor Board 2021-22

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.